How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice
To the Editor, The exact time to stop bladder cancer patient’s follow-up is not well known and there is not a clear recommendation on if and when stop to follow a patient managed for muscle invasive bladder cancer (MIBC). Major urological guidelines do not provide a precise indication on the tim...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2022-09-01
|
| Series: | Archivio Italiano di Urologia e Andrologia |
| Subjects: | |
| Online Access: | https://www.pagepressjournals.org/index.php/aiua/article/view/10681 |
| _version_ | 1811258621889085440 |
|---|---|
| author | Aldo Franco De Rose Francesco Vecco Francesca Ambrosini Rafaela Malinaric Guglielmo Mantica Carlo Terrone |
| author_facet | Aldo Franco De Rose Francesco Vecco Francesca Ambrosini Rafaela Malinaric Guglielmo Mantica Carlo Terrone |
| author_sort | Aldo Franco De Rose |
| collection | DOAJ |
| description |
To the Editor,
The exact time to stop bladder cancer patient’s follow-up is not well known and there is not a clear recommendation on if and when stop to follow a patient managed for muscle invasive bladder cancer (MIBC). Major urological guidelines do not provide a precise indication on the timing of follow-up, and there is currently no real consensus on optimal time schedule [...].
|
| first_indexed | 2024-04-12T18:17:11Z |
| format | Article |
| id | doaj.art-cc5341e1461d4293864779c693e44982 |
| institution | Directory Open Access Journal |
| issn | 1124-3562 2282-4197 |
| language | English |
| last_indexed | 2024-04-12T18:17:11Z |
| publishDate | 2022-09-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Archivio Italiano di Urologia e Andrologia |
| spelling | doaj.art-cc5341e1461d4293864779c693e449822022-12-22T03:21:34ZengPAGEPress PublicationsArchivio Italiano di Urologia e Andrologia1124-35622282-41972022-09-0194310.4081/aiua.2022.3.369How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practiceAldo Franco De Rose0Francesco Vecco1Francesca Ambrosini2Rafaela Malinaric3Guglielmo Mantica4Carlo Terrone5IRCCS Ospedale Policlinico San Martino, GenovaIRCCS Ospedale Policlinico San Martino, Genova; Università di Genova, (DISC), GenovaIRCCS Ospedale Policlinico San Martino, Genova; Università di Genova, (DISC), GenovaIRCCS Ospedale Policlinico San Martino, Genova; Università di Genova, (DISC), GenovaIRCCS Ospedale Policlinico San Martino, GenovaIRCCS Ospedale Policlinico San Martino, Genova; Università di Genova, (DISC), Genova To the Editor, The exact time to stop bladder cancer patient’s follow-up is not well known and there is not a clear recommendation on if and when stop to follow a patient managed for muscle invasive bladder cancer (MIBC). Major urological guidelines do not provide a precise indication on the timing of follow-up, and there is currently no real consensus on optimal time schedule [...]. https://www.pagepressjournals.org/index.php/aiua/article/view/10681MIBCfollow uprecurrenceurethrailealconduit |
| spellingShingle | Aldo Franco De Rose Francesco Vecco Francesca Ambrosini Rafaela Malinaric Guglielmo Mantica Carlo Terrone How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice Archivio Italiano di Urologia e Andrologia MIBC follow up recurrence urethra ilealconduit |
| title | How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice |
| title_full | How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice |
| title_fullStr | How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice |
| title_full_unstemmed | How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice |
| title_short | How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice |
| title_sort | how long should we follow patients managed for muscle invasive bladder cancer lesson learned from a recent clinical practice |
| topic | MIBC follow up recurrence urethra ilealconduit |
| url | https://www.pagepressjournals.org/index.php/aiua/article/view/10681 |
| work_keys_str_mv | AT aldofrancoderose howlongshouldwefollowpatientsmanagedformuscleinvasivebladdercancerlessonlearnedfromarecentclinicalpractice AT francescovecco howlongshouldwefollowpatientsmanagedformuscleinvasivebladdercancerlessonlearnedfromarecentclinicalpractice AT francescaambrosini howlongshouldwefollowpatientsmanagedformuscleinvasivebladdercancerlessonlearnedfromarecentclinicalpractice AT rafaelamalinaric howlongshouldwefollowpatientsmanagedformuscleinvasivebladdercancerlessonlearnedfromarecentclinicalpractice AT guglielmomantica howlongshouldwefollowpatientsmanagedformuscleinvasivebladdercancerlessonlearnedfromarecentclinicalpractice AT carloterrone howlongshouldwefollowpatientsmanagedformuscleinvasivebladdercancerlessonlearnedfromarecentclinicalpractice |